Terms: = Lung cancer AND WIF1, WIF-1, 11197, ENSG00000156076 AND Prognosis
10 results:
1. Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC.
Simiene J; Dabkeviciene D; Stanciute D; Prokarenkaite R; Jablonskiene V; Askinis R; Normantaite K; Cicenas S; Suziedelis K
BMC Cancer; 2023 Sep; 23(1):857. PubMed ID: 37697308
[TBL] [Abstract] [Full Text] [Related]
2. The status of wif1 methylation in cell-free DNA is associated with the insusceptibility for gefitinib in the treatment of lung cancer.
Shen Z; Chen C; Sun J; Huang J; Liu S
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2239-2248. PubMed ID: 34037837
[TBL] [Abstract] [Full Text] [Related]
3. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
Ni KW; Sun GZ
Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
[TBL] [Abstract] [Full Text] [Related]
4. Tumor Suppressive Role of ARHGAP17 in Colon cancer Through Wnt/β-Catenin Signaling.
Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
Cell Physiol Biochem; 2018; 46(5):2138-2148. PubMed ID: 29730655
[TBL] [Abstract] [Full Text] [Related]
5. Promoter hypermethylation of Wnt inhibitory factor-1 in patients with lung cancer: A systematic meta-analysis.
Zheng Y; Li X; Jiang Y; Xu Y; Song B; Zhou Q; Liang X; Yang X
Medicine (Baltimore); 2016 Dec; 95(49):e5433. PubMed ID: 27930522
[TBL] [Abstract] [Full Text] [Related]
6. wif-1 and Ihh Expression and Clinical Significance in Patients With lung Squamous Cell Carcinoma and Adenocarcinoma.
Zhang Y; Hu C
Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):454-461. PubMed ID: 27801732
[TBL] [Abstract] [Full Text] [Related]
7. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer.
Stewart DJ; Chang DW; Ye Y; Spitz M; Lu C; Shu X; Wampfler JA; Marks RS; Garces YI; Yang P; Wu X
Pharmacogenomics J; 2014 Dec; 14(6):509-22. PubMed ID: 24980784
[TBL] [Abstract] [Full Text] [Related]
8. Wnt signaling pathway in non-small cell lung cancer.
Stewart DJ
J Natl Cancer Inst; 2014 Jan; 106(1):djt356. PubMed ID: 24309006
[TBL] [Abstract] [Full Text] [Related]
9. wif1 hypermethylation as unfavorable prognosis of non-small cell lung cancers with EGFR mutation.
Lee SM; Park JY; Kim DS
Mol Cells; 2013 Jul; 36(1):69-73. PubMed ID: 23686431
[TBL] [Abstract] [Full Text] [Related]
10. Promoter hypermethylation of the p16 and wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers.
Yoshino M; Suzuki M; Tian L; Moriya Y; Hoshino H; Okamoto T; Yoshida S; Shibuya K; Yoshino I
Int J Oncol; 2009 Nov; 35(5):1201-9. PubMed ID: 19787276
[TBL] [Abstract] [Full Text] [Related]